Checkpoint Inhibitor-Associated Diabetes Mellitus Following Rapid Pancreatic Metastasis Resolution: Implications for Endocrine Toxicities in Immunotherapy
CIADM may emerge as an immune-related adverse event in patients with rapid pancreatic tumor response. Early recognition is essential, particularly in those with pronounced tumor regression, to ensure timely diagnosis and management.
Authors
- Deirdre Kelly (ORCID: https://orcid.org/0000-0002-4853-5712)
- Nigel Glynn (ORCID: https://orcid.org/0000-0002-9248-8191)
- Sadhbh Doherty
- Sinead Cadogan
Institutions
- Mater Misericordiae University Hospital (IE)
Publication Details
- Journal
- AACE Endocrinology and Diabetes
- Published
- 2025-09-02
- DOI
- https://doi.org/10.1016/j.aed.2025.08.014
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05